Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Sny crawled date : 2021 - 05 - 17 save search
Five ways to improve your business with Business Services
Published: 2021-05-17 (Crawled : 19:00) - modeln.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.22%
H: 0.1%
C: -0.26%
Positive Phase II Results Show There's Still Hope for the Sanofi/GSK COVID-19 Vaccine
Published: 2021-05-17 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
covid positive results vaccine covid-19
Positive Phase II Results Show There's Still Hope for the Sanofi/GSK COVID-19...
Published: 2021-05-17 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
covid positive results covid-19
Phase 3 Data Presented at ATS 2021 Show REGEN-COV™ (casirivimab with imdevimab) Reduced Risk of Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients
Published: 2021-05-17 (Crawled : 14:15) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.03%
H: 1.84%
C: 1.41%
covid risk casirivimab phase 3
Escient Pharmaceuticals Appoints Christian Weyer, M.D., M.A.S., as President and Chief Medical Officer
Published: 2021-05-17 (Crawled : 14:15) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
eye
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks and improved lung function in children
Published: 2021-05-17 (Crawled : 14:15) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.03%
H: 1.84%
C: 1.41%
children dupixent
ESPERION Appoints Sheldon Koenig as President and CEO
Published: 2021-05-17 (Crawled : 13:15) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
ESPR | $1.94 3.74% 3.61% 7.3M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: -8.1%
ceo leo
AavantiBio Rounds Out Leadership Team with Appointment of Jessie Hanrahan, Ph.D. as Chief Regulatory Officer
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: -0.12%
H: 0.77%
C: 0.53%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: -1.06%
H: 2.33%
C: -0.3%
IBIO | $1.72 -2.83% 0.0% 95K
|
Health Technology
|
| O: -7.48%
H: 6.44%
C: 0.0%
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial
Published: 2021-05-17 (Crawled : 06:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
covid phase 2 vaccine trial response
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.